Edjah K. Nduom, MD, FAANS
-
RoleNeurosurgery
-
Specialty
-
Research Program
-
Practicing Since2015
Background
Edjah K. Nduom, MD, FAANS, is a professor in the Department of Neurosurgery at Emory University School of Medicine. A fellowship-trained and board certified neurosurgical oncologist, Dr. Nduom's clinical specialty is the surgical management of brain and spinal cord tumors. He is particularly interested in the safe resection of malignant tumors located in eloquent areas of the brain, the brainstem and spinal cord.
Dr. Nduom serves as leader of the Brain Tumor Disease Team at Winship Cancer Institute of Emory University. In this role, he leads the multidisciplinary disease team in advancing clinical, translational and catchment-area priorities for brain tumors aligned with Winship's Strategic Plan.
Dr. Nduom's research focuses on the modulation of the immune system for the treatment of malignant brain tumors. He has presented his translational and clinical work on immune therapy for brain tumors at numerous national and international meetings.
Titles & Roles
-
Daniel Louis Barrow Endowed Chair in NeurosurgeryEmory University School of Medicine
-
Professor, Department of NeurosurgeryEmory University School of Medicine
-
Leader, Brain Tumor Disease TeamWinship Cancer Institute of Emory University
Education & Training
Education
- Fellowship, Neurological Surgery, 2015UT MD Anderson Cancer Center
- Residency, Neurological Surgery, 2013Emory University School of Medicine
- Fellowship, Neurological Surgery, 2012National Institute of Health, Clinic Center
- Medical Education, MD, 2006University of Pennsylvania Perelman School of Medicine
Board Certifications
- Neurological SurgeryAmerican Board of Neurological Surgery, 2019
Professional Memberships
Dr. Nduom is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University. He holds numerous positions in national and international medical societies. Notably, he is Co-Founder and Diasporan Representative of the Society for Neuro-Oncology Sub-Saharan Africa; International Outreach Committee Co-Chair of the Society for Neuro-Oncology; Membership Director of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and Member of the Board of Directors of the National Brain Tumor Society.
Research
Publications
Title/Journal Authors Publication Date Patient-Derived Meningioma Organoids: A Reliable Model for Studying Human Tumor Pathophysiology.
Cancers
YM Zohdy, A Jahangiri, F Jacob, A Aksionau, AM Alawieh, A Tong, B Chern, J Maldonado, K Hoang, E Nduom, BM Howard, DL Barrow, SG Neill, Z Wen, G Pradilla, T Garzon-Muvdi 02/05/2025 Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma.
Nature cell biology
C Sojka, HV Wang, TN Bhatia, Y Li, P Chopra, A Sing, A Voss, A King, F Wang, K Joseph, VM Ravi, J Olson, K Hoang, E Nduom, VG Corces, B Yao, SA Sloan 02/01/2025 Financial Toxicity in High-Grade Glioma Resection: A Retrospective Analysis.
World neurosurgery
NM Stubbs, JA Garner, T Akinwunmi-Williams, J Jani, S Ngo, T Ma, E Robinson, T Jackson, J Olson, K Huntoon, EK Nduom, KB Hoang 02/01/2025 Nature communications
CS Jansen, MS Pagadala, MA Cardenas, RS Prabhu, S Goyal, C Zhou, P Chappa, BT Vo, C Ye, B Hopkins, J Zhong, A Klie, T Daniels, M Admassu, I Green, NT Pfister, SG Neill, JM Switchenko, N Prokhnevska, KB Hoang, MA Torres, S Logan, JJ Olson, EK Nduom, L Del Balzo, K Patel, SH Burri, AL Asher, S Wilkinson, R Lake, AH Kesarwala, KA Higgins, P Patel, V Dhere, AG Sowalsky, H Carter, MK Khan, H Kissick, ZS Buchwald 10/14/2024 A brave new framework for glioma drug development.
The Lancet. Oncology
KM Hotchkiss, P Karschnia, KC Schreck, M Geurts, TF Cloughesy, J Huse, ES Duke, J Lathia, DM Ashley, EK Nduom, G Long, K Singh, A Chalmers, MS Ahluwalia, A Heimberger, S Bagley, T Todo, R Verhaak, PD Kelly, S Hervey-Jumper, J de Groot, A Patel, P Fecci, I Parney, V Wykes, C Watts, TC Burns, N Sanai, M Preusser, JC Tonn, KJ Drummond, M Platten, S Das, K Tanner, MA Vogelbaum, M Weller, JR Whittle, MS Berger, M Khasraw 10/01/2024 Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
Journal of neuro-oncology
DP Bray, NM Stubbs, J Chow, A Jahangiri, EK Nduom, JJ Olson, KB Hoang 07/01/2024 Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis.
Cancers
M Mayol Del Valle, B Morales, B Philbrick, S Adeagbo, S Goyal, S Newman, NL Frontera, E Nduom, J Olson, S Neill, K Hoang 01/18/2024 Neuro-oncology advances
A Li, JC Hancock, M Quezado, S Ahn, N Briceno, O Celiku, S Ranjan, O Aboud, N Colwell, SA Kim, E Nduom, S Kuhn, DM Park, E Vera, K Aldape, TS Armstrong, MR Gilbert 01/01/2024 Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors.
Current treatment options in oncology
B Ndirangu, K Bryan, E Nduom 12/01/2023 Promoting diversity in neurosurgery through a virtual symposium.
Journal of neurosurgery
AJ Charles, A Seas, J Corley, JB Duvall, E Owolo, N Abu-Bonsrah, AA Elsamadicy, V Simpson, O Sanusi, LT Holly, A Rodriguez, EK Nduom, AD Levi, LM Liau, A Quiñones-Hinojosa, I Karikari, G Grant, AT Fuller, CR Goodwin 10/01/2023 Cancers
SS Mannam, DP Bray, CD Nwagwu, J Zhong, HK Shu, B Eaton, L Sudmeier, S Goyal, C Deibert, EK Nduom, J Olson, KB Hoang 09/28/2023 Research square
CS Jansen, RS Prabhu, MS Pagadala, P Chappa, S Goyal, C Zhou, SG Neill, N Prokhnevska, M Cardenas, KB Hoang, J Zhong, M Torres, S Logan, JJ Olson, EK Nduom, L Del Balzo, K Patel, SH Burri, AL Asher, S Wilkinson, R Lake, KA Higgins, P Patel, V Dhere, AG Sowalsky, MK Khan, H Kissick, ZS Buchwald 03/23/2023 Mass shootings in the United States: an alarming trend of violence and public health threat.
Journal of neurosurgery
CA Spence, SV Eden, B Pennicooke, O Adogwa, LT Holly, BG Welch, N Mbabuike, E Nduom, WW Ashley 03/01/2023 PLOS global public health
EJ Barthélemy, SA Diouf, ACV Silva, N Abu-Bonsrah, IAS de Souza, US Kanmounye, P Gabriel, K Sarpong, EK Nduom, JW Lartigue, I Esene, C Karekezi 01/01/2023 PloS one
EK Nduom, J Glod, DA Brown, M Fagan, M Dalmage, J Heiss, SM Steinberg, C Peer, WD Figg, S Jackson 01/01/2023 Letter to the Editor. Diversity-related studies in neurosurgery: concerns and suggestions.
Journal of neurosurgery. Spine
LT Holly, WW Ashley, EK Nduom, B Pennicooke, CA Spence, BG Welch 11/01/2022 Neuro-oncology
BM Ellingson, ER Gerstner, AB Lassman, C Chung, H Colman, PE Cole, D Leung, JE Allen, MS Ahluwalia, J Boxerman, M Brown, J Goldin, E Nduom, I Hassan, MR Gilbert, IK Mellinghoff, M Weller, S Chang, D Arons, C Meehan, W Selig, K Tanner, WK Alfred Yung, M van den Bent, PY Wen, TF Cloughesy 08/01/2022 Neurosurgery
MM Del Valle, EK Nduom, J Olson, KB Hoang 06/01/2022 Cell reports. Medicine
LJ Sudmeier, KB Hoang, EK Nduom, A Wieland, SG Neill, MJ Schniederjan, SS Ramalingam, JJ Olson, R Ahmed, WH Hudson 05/17/2022 Scientific reports
VE Sanchez, JP Lynes, S Walbridge, X Wang, NA Edwards, AK Nwankwo, HP Sur, GA Dominah, A Obungu, N Adamstein, PK Dagur, D Maric, J Munasinghe, JD Heiss, EK Nduom 04/04/2022 Journal of neuro-oncology
D Grogan, DP Bray, M Cosgrove, A Boucher, A Erwood, DF Linder, P Mendoza, B Morales, G Pradilla, EK Nduom, S Neill, JJ Olson, KB Hoang 03/01/2022 Guidelines for optimal utilization of social media for brain tumor stakeholders.
Journal of neurosurgery
N Hamidi, B Karmur, S Sperrazza, J Alexieva, L Salmi, BE Zacharia, EK Nduom, AA Cohen-Gadol, JT Rutka, A Mansouri 02/01/2022 Neurosurgery
DP Bray, KB Hoang, EK Nduom, JJ Olson 02/01/2022 Neuro-oncology advances
MR Dalmage, A Nwankwo, H Sur, E Nduom, S Jackson 01/01/2022 Neuro-oncology advances
DP Bray, H Saad, JM Douglas, D Grogan, RA Dawoud, J Chow, C Deibert, G Pradilla, EK Nduom, JJ Olson, AM Alawieh, KB Hoang 01/01/2022 Neurosurgery
AM Khalafallah, M Rakovec, C Bettegowda, CM Jackson, GL Gallia, JD Weingart, M Lim, Y Esquenazi, BE Zacharia, E Goldschmidt, M Ziu, ME Ivan, AS Venteicher, EK Nduom, AN Mamelak, RM Chu, JS Yu, JP Sheehan, BV Nahed, BS Carter, MS Berger, R Sawaya, D Mukherjee 09/15/2021 Neurosurgery
EK Nduom, MH Gephart, MG Chheda, ML Suva, N Amankulor, JD Battiste, JL Campian, RG Dacey, S Das, PE Fecci, CG Hadjipanayis, KB Hoang, A Jalali, D Orringer, AJ Patel, D Placantonakis, A Rodriguez, I Yang, JS Yu, GJ Zipfel, GP Dunn, EC Leuthardt, AH Kim 06/15/2021 Letter: A Call to Action: Increasing Black Representation in Neurological Surgery.
Neurosurgery
DK Detchou, A Onyewuenyi, V Reddy, A Boyke, N Mbabuike, WW Ashley, EK Nduom 04/15/2021 Why would a black man volunteer for a government-funded science experiment?
EClinicalMedicine
EK Nduom 03/01/2021 Neuro-oncology
J Balogun, C Haynes, Z Lwin, E Nduom, V Puduvalli, M Venere, G Zadeh 11/26/2020 Brain Tumor Discussions on Twitter (#BTSM): Social Network Analysis.
Journal of medical Internet research
JT Feliciano, L Salmi, C Blotner, A Hayden, EK Nduom, BM Kwan, MS Katz, EB Claus 10/08/2020 Neurosurgery clinics of North America
EK Nduom, JJ Olson 10/01/2020 Advanced therapeutics
R Medina, H Wang, V Caisová, J Cui, IH Indig, O Uher, J Ye, A Nwankwo, V Sanchez, T Wu, E Nduom, J Heiss, MR Gilbert, M Terabe, W Ho, J Zenka, K Pacak, Z Zhuang 09/01/2020 Journal of neuro-oncology
J Lynes, AA Acquaye, H Sur, A Nwankwo, V Sanchez, E Vera, T Wu, B Theeler, TS Armstrong, MR Gilbert, EK Nduom 08/01/2020 Frontiers in oncology
G Yu, MK Butler, A Abdelmaksoud, Y Pang, YT Su, Z Rae, K Dadkhah, MC Kelly, YK Song, JS Wei, M Terabe, R Atony, K Mentges, BJ Theeler, M Penas-Prado, J Butman, K Camphausen, KA Zaghloul, E Nduom, M Quezado, K Aldape, TS Armstrong, MR Gilbert, JL Gulley, J Khan, J Wu 01/01/2020 Awards
Dr. Nduom has received several awards over the course of his career. Recent awards include:
- Academy Emerging Investigator by the American Academy of Neurological Surgery
- National Institutes of Health Director's Award
- 40 under 40 Leader in Minority Health by the National Minority Quality Forum
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.9 Provider showed concern 4.9 Provider explained things clearly 4.9 Provider discussed treatment options 4.8 Provider included you in decisions 4.9 Likelihood of recommending this provider